Skip to content

WristArt Total Wrist Arthroplasty Implant First In Human Study

WristArt Total Wrist Arthroplasty Implant First In Human Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06196528
Enrollment
5
Registered
2024-01-09
Start date
2024-01-02
Completion date
2026-02-28
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrist Osteoarthritis

Brief summary

The WristArt implant will be implanted for the first time in humans' wrists

Interventions

DEVICEWristArt implant

implantation of the WristArt implant

Sponsors

Fibioseq Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subjects suffering from one the following conditions: 1. Osteoarthritis (OA) of the wrist joint due to various causes (age, trauma, Avascular Necrosis) 2. Rheumatoid arthritis of the wrist joint or other rheumatological diseases which destroy the wrist joint 3. Unrepairable previous intraarticular fractures of the distal radius, scaphoid or lunate bones of the wrist joint (i.e., historical fractures that were failed to fuse surgically) 4. Symptomatic congenital abnormalities around wrist joint such as carpal bones coalition, mild forms of Madelung's deformities etc. 5. Patients who underwent failed proximal row carpectomy, or failed partial carpal bones fusion 2. Patients who's their wrist x-ray shows no damage to the carpal bones that are not fused as part of the surgery 3. Patient Rated Wrist Evaluation Score (PRWE) at baseline is above 70 points out of 100 4. Visual Analog Pain Score (VAS) at baseline is above 70 points out of 100

Exclusion criteria

1. Patients younger than 18 years old 2. Patients for whom bone growth did not complete yet 3. Paralytic hand patients 4. Patients with sensitivity to Titanium (ADD/CHANGE MATERIALS AS NEEDED) 5. Cerebral palsy patients with wrist joint contracture and loss of sensation in the hand 6. Low quality of capitate bone and/or excessively short capitate bone (≥50% destruction) due to various causes (AVN, comminuted fracture, lytic lesions, congenital etc.)

Design outcomes

Primary

MeasureTime frameDescription
Number of Device Related Serious Adverse events at 6 months post operation6 months post operationImplantation Safety profile at 6 months post operation
Number of cases with Fully and successfully implanted device at the end of surgery per surgeon's reporting and radiological imaging48 hours post-surgeryImplantation Success profile at the end of surgery

Secondary

MeasureTime frameDescription
Average levels of change in functionality according to Patient Reported Wrist Evaluation (PRWE)1 month, 3 months, 6 months, 1 year, 2 yearsThe PRWE is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. scores range from 0 (no disability) to 100 (worse functional score)
Average levels of change in Grip Strength as measured by dynamometer1 month, 3 months, 6 months, 1 year, 2 yearslevels of change in Grip Strength as measured by a dynamometer
Average levels of change in Range of motion as measured by a goniometer1 month, 3 months, 6 months, 1 year, 2 yearslevels of change in Range of motion
Number of Device Related Serious Adverse events at 24 months post operation24 months following implantationImplantation Safety profile at 24 months post operation
Metal Ion Levels in blood at 1 year following surgery1 yearMetal Ion Levels in blood at 1 year following surgery
Average Surgical Satisfaction Questionnaire (SSQ-8)1 yearSSQ8 is a 8-items instrument, with responses recorded on a 5-point Likert-type scale from 0 (worst) to 4 (best) and an overall score ranging from 0 (very unsatisfied) to 32 (very satisfied)
Levels of change in functionality according to quick DASH scores (0 - full function ; 100 - impaired functionality)1 month, 3 months, 6 months, 1 year, 2 yearsLevels of change in functionality according to quick DASH scores
Implant loosening rate per radiological measurements1 month, 3 months, 6 months, 1 year, 2 yearsImplant loosening rate per radiological measurements
Average Pain Reduction levels according to Visual Analog Pain Score (VAS)1 month, 3 months, 6 months, 1 year, 2 yearsPain is calculated using a visual analog scale ranges from 1-10 (taken from the pain subscale of the Patient Reported Wrist Evaluation PRWE scale)

Countries

Israel

Contacts

Primary ContactAmir Oron, MD
amiroronmd@gmail.com972-8-9441340
Backup ContactShiran Rogof
shiranro1@clalit.org.il+97289441340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026